Sabra Healthcare REIT (SBRA) to Release Quarterly Earnings on Monday

Sabra Healthcare REIT (NASDAQ:SBRA) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Monday, August 4th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $185.64 million for the quarter. Sabra Healthcare REIT has set its FY 2025 guidance at 1.430-1.460 EPS.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.01. The company had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. Sabra Healthcare REIT had a return on equity of 5.14% and a net margin of 19.55%. The firm’s revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.35 earnings per share. On average, analysts expect Sabra Healthcare REIT to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Healthcare REIT Price Performance

Shares of Sabra Healthcare REIT stock opened at $18.29 on Friday. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.89. The company has a market cap of $4.35 billion, a PE ratio of 31.00, a P/E/G ratio of 1.49 and a beta of 0.86. The business has a 50 day moving average of $18.14 and a 200 day moving average of $17.50. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $20.03.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 30th. Investors of record on Friday, May 16th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.6%. The ex-dividend date was Friday, May 16th. Sabra Healthcare REIT’s dividend payout ratio is currently 203.39%.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the transaction, the director owned 64,725 shares in the company, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.20% of the company’s stock.

Hedge Funds Weigh In On Sabra Healthcare REIT

An institutional investor recently raised its position in Sabra Healthcare REIT stock. Focus Partners Wealth grew its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 11.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,146 shares of the real estate investment trust’s stock after acquiring an additional 2,375 shares during the quarter. Focus Partners Wealth’s holdings in Sabra Healthcare REIT were worth $404,000 as of its most recent SEC filing. 99.40% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Scotiabank upped their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a report on Monday, June 23rd. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $19.67.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.